PUBLISHED DATE : Jan 2023 | Pages : 367
Fill out your details & get your free sample
The Global Pharmaceutical Logistics Market Size, Share, And Growth Forecast By:
Industry Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share, & Forecast 2022-2027
367 Pages
98 Tables
219 Charts
5 Regions
18 Countries
35 Companies
5 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2027) | USD 146.71 BILLION |
| Market Size (2021) | USD 92.66 BILLION |
| CAGR (2021-2027) | 7.96% |
| Base Year | 2021 |
| Forecast Year | 2022-2027 |
| Market Segments | Therapy Area, Origin, Product, Function, and Geography |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY VENDORS | AmerisourceBergen, CEVA Logistics, DB Group, Deutsche Post DHL, FedEx, Kuehne + Nagel, and United Parcel Service |
The global pharmaceutical logistics market size was estimated at USD 92.66 billion in 2021 and is expected to reach USD 146.71 billion by 2027, growing with an estimated CAGR of 7.97% during the forecast period. Technological advancements are disrupting the logistics providers to improve the healthcare business model ecosystem, including pharmaceuticals. Further, increased usage of logistics optimization tools, AI, IoT, and intelligent logistics platforms are likely to contribute to the future growth of the pharmaceutical logistics market.
Pharmaceutical logistics deals with manufacturing, processing, shipping materials, and resources and activities related to handling manufactured goods by their customers. Logistics companies play a crucial role in the functioning of any pharmaceutical company. The growing adoption of water-based pharmaceutical logistics is one of the significant driving factors in the pharmaceutical logistics market. Pharmaceutical logistics showed a healthy growth rate even before the COVID-19 pandemic. The sector is undergoing several changes as the geriatric population drives the need for new pharma solutions. However, the COVID-19 pandemic has created complexities in the global supply chain that has impacted all the modes of freight transportation, from air to rail cargo, that may take months or years to get back to normal.
Clinical research has recently become more globalized, with many of these studies being conducted globally and a significant increase in clinical trials in developing countries. The focus of clinical trial researchers is now shifting from developed markets of Japan, Australia, South Korea, and Singapore towards emerging economies like Thailand, China, the Philippines, and Vietnam.
Major companies are striving to offer cloud-based supply chain services and secured supply chain functions as it helps pharmaceutical manufacturers safeguard the validity of the drugs. These solutions are expected to prevent the production and distribution of counterfeit drugs. According to DB Schenker, a subsidiary of DB Group, to increase transport density and reliability, the shift to digital rail operations and digitalization of infrastructure and vehicles is essential in the pharmaceutical logistics market. Also, in 2019, TrakCel, one of the global leaders in managing clinical supply chain logistics, partnered with Quick Group to provide industry-leading digital supply chain IT solutions for cell and gene therapies. Also, the recent emergence of cell and gene therapy is expected to create lucrative opportunities for the pharmaceutical logistics market.
Driving Factors Of The Global Pharmaceutical Logistics Market:
INSIGHTS BY THERAPY AREA
In therapy area segmentation, the communicable diseases segment dominated the global pharmaceutical logistics market with a share of 19.96% owing to the emergence of the COVID-19 pandemic that upsurged the communicable disease cases. According to the latest European Centre for Disease Prevention and Control (ECDC) report, tuberculosis remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern that is made the communicable diseases dominant in the last few years. In 2019, communicable diseases ranked third with the highest number of cases, while the emergence of the COVID-19 pandemic dominated the segment in 2021. The upsurge in COVID-19 cases contributed to the highest share of communicable diseases, leading to increased demand for OTC medicines and vaccines.
The oncology segment accounted for the second-largest segment in the pharmaceutical logistics market with a revenue share of 15.17%, owing to growing cancer prevalence and demand for anti-tumor agents. It is also expected to grow at the highest CAGR of 14.02%. The current pharmaceuticals pipeline is disproportionately focused on cancer.
The world is expecting more pandemics in the future, particularly with monkeypox spreading in more than 60 countries which are expected to drive the demand for new medications and more clinical trials, thus boosting the demand for logistics during clinical trials and distributing products.
INSIGHTS BY ORIGIN
Under origin segmentation, branded drugs accounted for the highest revenue share in the global pharmaceutical logistics market. This is mainly due to their high preference and the high cost of branded drugs, which makes up the high revenue share of pharmaceutical logistics for branded drugs. According to the Association for Accessible Medicines, US Generic & Biosimilar Medicines Savings Report and National Sales Perspectives, in December 2020, branded drugs spending was around 80% of the share from 2018-2020. However, the generic drugs segment is expected to grow at the highest CAGR of 72.25% during the forecast period.
INSIGHTS BY PRODUCT
Under product segmentation, small molecule drugs dominate the global pharmaceutical logistics market with a revenue share of 63.02% in 2021 due to increasing demand and its cost-effectiveness, ease of administration, and easy dosing. The demand for small-molecule drugs remains high, with figures showing that 97% of marketed drugs are classified as small molecules. However, biologics lead among the top-selling products and new sales generators projected for 2022, whereas small molecules continue to lead in new drug approvals. According to US FDA’s Center for Drug Evaluation and Research, of the 50 new molecular entities approved by the US FDA’s Center for Drug Evaluation and Research in 2021, 36 (72%) were small molecules, and 14(28%) were biologics.
INSIGHTS BY FUNCTION
As transportation is a crucial part of the logistics chain, thus it accounts for the highest revenue share of 71.66% in the pharmaceutical logistics market in 2021 and continues to grow with the highest CAGR of 8.20% during the forecast period. The demand for temperature-controlled transportation is also rising to maintain the quality of the products. Road transportation dominates the transportation segment with a revenue share of 66.38% in 2021, whereas the water and air transportation segments accounted for 21.21% and 12.41%, respectively, in the same year. The highest share of road transportation can be attributed to its low cost in terms of workforce and operation. In January 2021, more than 58% of US-Canada cross-border freight was moved by trucks, followed by rail with more than 16% of cross-border freight.
However, in 2020, European land transport declined because of the COVID-19 pandemic. Between April and August 2020, after decreased prices and falling demand, prices grew exponentially to the previous year’s level from October 2020, and the demand increased significantly. As the air rates are higher than water and road, thus the demand for logistics via air is lowest.
Air freight is 78% more expensive than ocean freight, leading the pack with 80% of all temperature excursions for pharmaceutical products transportation. In comparison, ocean transportation has a mere 1% temperature excursion rate, while road transport is a little higher, with 18% of all the excursions. There is still a lot of work for the air cargo supply chain to come up to speed for the growing global trade in pharmaceutical products. Despite that, the global pharmaceutical logistics market by air is growing at the fastest CAGR of 9.16% during the forecast period.
North America region accounts for the highest revenue share of 38.70% in the global pharmaceutical logistics market in 2021 and holds the presence of most pharmaceutical suppliers. The US is the leading country worldwide with the highest share of pharmaceuticals. About five of the ten top pharmaceutical companies in 2020 were from the US. In the US, branded drugs accounted for around 83.9% of spending. In 2020, about 8.1% of worldwide drug and medicine shipments originated from North America.
North America and Europe have accounted for about 80% of monoclonal antibodies market share alone; thus, the growing demand for biologics, i.e., vaccines and monoclonal antibodies, and increasing investments in R&D are the major driving factors for the pharmaceutical logistics market. Europe is the number one exporter of pharmaceutical drugs. The pharmaceutical logistics demand in Europe is driven by the growing demand for biologics such as vaccines, propelled by the COVID-19 pandemic and growing investments by leading pharmaceutical firms. In 2019, pharmaceutical industry sales in the country increased by 5.7%, reaching about USD 52.1 billion. More than 500 pharmaceutical companies are in Germany. Small and mid-size enterprises (SMEs) constitute the backbone of the economic sector, with around 90% of drug manufacturers. In 2018, Germany generated a production value of USD 42.1 billion, making it the leading pharmaceutical manufacturing country in Europe.
The pharmaceutical logistics market in APAC was valued at USD 20.79 billion in 2021. Asia Pacific is the largest manufacturing region and provider of generic drugs, vaccines, OTC drugs, biosimilars, custom research manufacturing, and active pharmaceutical ingredients; many countries are importing pharmaceuticals from this region. Hence, the growing demand for these pharmaceutical products is the major driving factor for transportation and warehousing activities in the region. India has the highest share of about 20% of the global supply volume. Moreover, it contributes to around 60% of global vaccines. India majorly exports biologics, which contribute to about 75% of the total pharmaceutical exports out of India. In addition, Latin America, the Middle East & Africa, and the APAC region are the major emerging markets for pharmaceutical logistics market growth. Factors such as rapid population growth, steady increase in the elderly population, and increased prevalence of chronic, non-communicable diseases are the major driving factors in these regions for growth in the pharmaceutical logistics market.
AmerisourceBergen, CEVA Logistics, Deutsch Post DHL, FedEx, Kuehne + Nagel, DB Schenker, and UPS are the key vendors in the pharmaceutical logistics market. These companies have a broad geographical footprint, a strong focus on innovation in logistics, and a diversified service portfolio. Upcoming new advanced technologies and increased demand for personalized medicines are providing lucrative opportunities for stakeholders to take the companies to the next level. Technologies such as data mining, mobile cloud, time analytics, and blockchain are expected to create better app interfaces and cloud infrastructure, which is expected to provide better growth opportunities in the post-pandemic pharmaceutical logistics market.
In addition to technological advances, companies invest in inorganic growth methods such as acquisitions. For instance, on June 2, 2021, the leading company, AmerisourceBergen, completed the acquisition of most of Walgreens Boots Alliance’s Alliance Healthcare businesses for USD 6.27 billion cash which will help the company expand its reach and solutions in pharmaceutical distribution. Similarly, In August 2021, the leading company Deutsche Post DHL Group, signed an agreement to acquire 100% of J.F. Hillebrand Group and its subsidiaries.
Frequently Asked Questions
How big is the pharmaceutical logistics market?
The pharmaceutical logistics market was valued at USD 92.66 billion in 2021 and is expected to reach USD 146.71 billion by 2027.
What is the pharmaceutical logistics market growth?
The global pharmaceutical logistics market is growing at a CAGR of 7.96% from 2021-2027.
What are the trends in the global pharmaceutical logistics market?
Growing Demand For Clinical Trials Logistics, Digital Transformations In Pharma Logistics, and Increasing Demand for Cell & Gene Therapy Logistics are the trends in the global pharmaceutical logistics market.
Which region holds the largest pharmaceutical logistics market share globally?
North America region holds the largest global pharmaceutical logistics market share. The region holds the huge presence of a majority of pharmaceutical suppliers. High acceptance, chronic disease prevalence, and the growing geriatric population are some factors contributing to this region's growth.
Which are the leading companies in the global pharmaceutical logistics market?
AmerisourceBergen, CEVA Logistics, DB Group, Deutsche Post DHL, FedEx, Kuehne + Nagel, and United Parcel Service are the leading companies in the global pharmaceutical logistics market.
What is the leading product in the pharmaceutical logistics market?
Small molecule drugs is the leading product in the global pharmaceutical logistics market, with a revenue share of 63.02%.
The pharmaceutical logistics market is expected to grow at a CAGR of approximately 7.96% from 2021 to 2027.
The following factors are likely to contribute to the growth of the pharmaceutical logistics market during the forecast period:
Base Year: 2021
Forecast Year: 2022-2027
The report considers the present scenario of the pharmaceutical logistics market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.
Key Vendors
Other Prominent Vendors
Segmentation by Therapy Area
Segmentation by Origin
Segmentation by Product
Segmentation by Function
Segmentation by Geography
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY THERAPY AREA
4.3.2 MARKET SEGMENTATION BY ORIGIN
4.3.3 MARKET SEGMENTATION BY PRODUCT
4.3.4 MARKET SEGMENTATION BY FUNCTION
4.3.5 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 BACKGROUND
7.2 IMPACT OF COVID-19 ON GLOBAL SUPPLY CHAIN
8 PREMIUM INSIGHTS
9 MARKET OPPORTUNITIES & TRENDS
9.1 GROWING DEMAND FOR CLINICAL TRIALS LOGISTICS
9.2 DIGITAL TRANSFORMATIONS IN PHARMA LOGISTICS
9.3 INCREASING DEMAND FOR CELL & GENE THERAPY LOGISTICS
10 MARKET GROWTH ENABLERS
10.1 INCREASING DEMAND FOR TEMPERATURE-SENSITIVE MEDICINES
10.2 GROWING DEMAND FOR OCEAN FREIGHT SERVICE
10.3 INCREASING DEMAND FOR GENERICS AND BIOSIMILARS
11 MARKET RESTRAINTS
11.1 LACK OF COMPLIANCE AND CHANGING REGULATIONS
11.2 IMPACT OF COVID-19 PANDEMIC
11.3 GEOPOLITICAL RISKS & CHANGES IN INTERNATIONAL TRADE POLICIES AND RELATIONS
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 INSIGHTS BY THERAPY AREA
12.2.2 INSIGHTS BY ORIGIN
12.2.3 INSIGHTS BY PRODUCT
12.2.4 INSIGHTS BY FUNCTION
12.2.5 INSIGHTS BY GEOGRAPHY
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 THERAPY AREA
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 COMMUNICABLE DISEASES
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 ONCOLOGY
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.5 DIABETES
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
13.6 CARDIOVASCULAR DISEASES
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
13.6.3 MARKET BY GEOGRAPHY
13.7 AUTOIMMUNE DISEASES
13.7.1 MARKET OVERVIEW
13.7.2 MARKET SIZE & FORECAST
13.7.3 MARKET BY GEOGRAPHY
13.8 NEUROLOGICAL DISORDERS
13.8.1 MARKET OVERVIEW
13.8.2 MARKET SIZE & FORECAST
13.8.3 MARKET BY GEOGRAPHY
13.9 PAIN MANAGEMENT
13.9.1 MARKET OVERVIEW
13.9.2 MARKET SIZE & FORECAST
13.9.3 MARKET BY GEOGRAPHY
13.10 RESPIRATORY DISEASES
13.10.1 MARKET OVERVIEW
13.10.2 MARKET SIZE & FORECAST
13.10.3 MARKET BY GEOGRAPHY
13.11 OTHERS
13.11.1 MARKET OVERVIEW
13.11.2 MARKET SIZE & FORECAST
13.11.3 MARKET BY GEOGRAPHY
14 ORIGIN
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 BRANDED DRUGS
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 GENERIC DRUGS
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 OTC
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
15 PRODUCT
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 SMALL MOLECULE DRUGS
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 BIOLOGICS
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
15.5 MONOCLONAL ANTIBODIES
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.6 VACCINES
15.6.1 MARKET OVERVIEW
15.6.2 MARKET SIZE & FORECAST
15.7 OTHERS
15.7.1 MARKET OVERVIEW
15.7.2 MARKET SIZE & FORECAST
16 FUNCTION
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 TRANSPORTATION
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 MARKET BY GEOGRAPHY
16.4 ROAD
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.5 WATER
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.6 AIR
16.6.1 MARKET OVERVIEW
16.6.2 MARKET SIZE & FORECAST
16.7 WAREHOUSING
16.7.1 MARKET OVERVIEW
16.7.2 MARKET SIZE & FORECAST
16.7.3 MARKET BY GEOGRAPHY
16.8 OTHERS
16.8.1 MARKET OVERVIEW
16.8.2 MARKET SIZE & FORECAST
16.8.3 MARKET BY GEOGRAPHY
17 GEOGRAPHY
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 GEOGRAPHIC OVERVIEW
18 NORTH AMERICA
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 NORTH AMERICA BY THERAPY AREA
18.4 NORTH AMERICA BY ORIGIN
18.5 NORTH AMERICA BY PRODUCT
18.6 NORTH AMERICA BY FUNCTION
18.7 KEY COUNTRIES
18.7.1 US: MARKET SIZE & FORECAST
18.7.2 CANADA: MARKET SIZE & FORECAST
19 EUROPE
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 EUROPE BY THERAPY AREA
19.4 EUROPE BY ORIGIN
19.5 EUROPE BY PRODUCT
19.6 EUROPE BY FUNCTION
19.7 KEY COUNTRIES
19.7.1 GERMANY: MARKET SIZE & FORECAST
19.7.2 FRANCE: MARKET SIZE & FORECAST
19.7.3 UK: MARKET SIZE & FORECAST
19.7.4 ITALY: MARKET SIZE & FORECAST
19.7.5 SPAIN: MARKET SIZE & FORECAST
20 APAC
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 APAC BY THERAPY AREA
20.4 APAC BY ORIGIN
20.5 APAC BY PRODUCT
20.6 APAC BY FUNCTION
20.7 KEY COUNTRIES
20.7.1 CHINA: MARKET SIZE & FORECAST
20.7.2 JAPAN: MARKET SIZE & FORECAST
20.7.3 INDIA: MARKET SIZE & FORECAST
20.7.4 SOUTH KOREA: MARKET SIZE & FORECAST
20.7.5 AUSTRALIA: MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 LATIN AMERICA BY THERAPY AREA
21.4 LATIN AMERICA BY ORIGIN
21.5 LATIN AMERICA BY PRODUCT
21.6 LATIN AMERICA BY FUNCTION
21.7 KEY COUNTRIES
21.7.1 BRAZIL: MARKET SIZE & FORECAST
21.7.2 MEXICO: MARKET SIZE & FORECAST
21.7.3 ARGENTINA: MARKET SIZE & FORECAST
22 MIDDLE EAST & AFRICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.3 MIDDLE EAST & AFRICA BY THERAPY AREA
22.4 MIDDLE EAST & AFRICA BY ORIGIN
22.5 MIDDLE EAST & AFRICA BY PRODUCT
22.6 MIDDLE EAST & AFRICA BY FUNCTION
22.7 KEY COUNTRIES
22.7.1 TURKEY: MARKET SIZE & FORECAST
22.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST
22.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST
23 COMPETITIVE LANDSCAPE
23.1 COMPETITION OVERVIEW
23.1.1 AMERISOURCEBERGEN
23.1.2 DB GROUP
23.1.3 DEUTSCHE POST DHL
23.1.4 CEVA LOGISTICS
23.1.5 UNITED PARCEL SERVICE
23.1.6 FEDEX
23.1.7 KUEHNE+NAGEL
24 KEY COMPANY PROFILES
24.1 AMERISOURCEBERGEN
24.1.1 BUSINESS OVERVIEW
24.1.2 SERVICE OFFERINGS
24.1.3 KEY STRATEGIES
24.1.4 KEY STRENGTHS
24.1.5 KEY OPPORTUNITIES
24.2 CEVA LOGISTICS
24.2.1 BUSINESS OVERVIEW
24.2.2 SERVICE OFFERINGS
24.2.3 KEY STRATEGIES
24.2.4 KEY STRENGTHS
24.2.5 KEY OPPORTUNITIES
24.3 DB GROUP
24.3.1 BUSINESS OVERVIEW
24.3.2 SERVICE OFFERINGS
24.3.3 KEY STRATEGIES
24.3.4 KEY STRENGTHS
24.3.5 KEY OPPORTUNITIES
24.4 DEUTSCHE POST DHL
24.4.1 BUSINESS OVERVIEW
24.4.2 SERVICE OFFERINGS
24.4.3 KEY STRATEGIES
24.4.4 KEY STRENGTHS
24.4.5 KEY OPPORTUNITIES
24.5 FEDEX
24.5.1 BUSINESS OVERVIEW
24.5.2 SERVICE OFFERINGS
24.5.3 KEY STRATEGIES
24.5.4 KEY STRENGTHS
24.5.5 KEY OPPORTUNITIES
24.6 KUEHNE + NAGEL
24.6.1 BUSINESS OVERVIEW
24.6.2 SERVICE OFFERINGS
24.6.3 KEY STRATEGIES
24.6.4 KEY STRENGTHS
24.6.5 KEY OPPORTUNITIES
24.7 UNITED PARCEL SERVICE
24.7.1 BUSINESS OVERVIEW
24.7.2 SERVICE OFFERINGS
24.7.3 KEY STRATEGIES
24.7.4 KEY STRENGTHS
24.7.5 KEY OPPORTUNITIES
25 OTHER PROMINENT VENDORS
25.1 ABS LOGISTICS
25.1.1 BUSINESS OVERVIEW
25.1.2 SERVICE OFFERINGS
25.2 AWL INDIA
25.2.1 BUSINESS OVERVIEW
25.2.2 SERVICE OFFERINGS
25.3 ALLOGA
25.3.1 BUSINESS OVERVIEW
25.3.2 SERVICE OFFERINGS
25.4 BOLLORÉ LOGISTICS
25.4.1 BUSINESS OVERVIEW
25.4.2 SERVICE OFFERINGS
25.5 CARDINAL HEALTH
25.5.1 BUSINESS OVERVIEW
25.5.2 SERVICE OFFERINGS
25.6 C.H. ROBINSON
25.6.1 BUSINESS OVERVIEW
25.6.2 SERVICE OFFERINGS
25.7 COLD CHAIN TECHNOLOGIES
25.7.1 BUSINESS OVERVIEW
25.7.2 SERVICE OFFERINGS
25.8 CRYOPDP
25.8.1 BUSINESS OVERVIEW
25.8.2 SERVICE OFFERINGS
25.9 DPD
25.9.1 BUSINESS OVERVIEW
25.9.2 SERVICE OFFERINGS
25.10 DSV
25.10.1 BUSINESS OVERVIEW
25.10.2 SERVICE OFFERINGS
25.11 FARMASOFT
25.11.1 BUSINESS OVERVIEW
25.11.2 SERVICE OFFERINGS
25.12 JEENA & COMPANY
25.12.1 BUSINESS OVERVIEW
25.12.2 SERVICE OFFERINGS
25.13 LUFTHANSA CARGO
25.13.1 BUSINESS OVERVIEW
25.13.2 SERVICE OFFERINGS
25.14 A.P. MOLLER - MAERSK
25.14.1 BUSINESS OVERVIEW
25.14.2 SERVICE OFFERINGS
25.15 MEDLINE
25.15.1 BUSINESS OVERVIEW
25.15.2 SERVICE OFFERINGS
25.16 NIPPON EXPRESS
25.16.1 BUSINESS OVERVIEW
25.16.2 SERVICE OFFERINGS
25.17 NOATUM LOGISTICS
25.17.1 BUSINESS OVERVIEW
25.17.2 SERVICE OFFERINGS
25.18 OWENS & MINOR
25.18.1 BUSINESS OVERVIEW
25.18.2 SERVICE OFFERINGS
25.19 OXIMIO
25.19.1 BUSINESS OVERVIEW
25.19.2 SERVICE OFFERINGS
25.20 PHARMA LOGISTICS
25.20.1 BUSINESS OVERVIEW
25.20.2 SERVICE OFFERINGS
25.21 PHOENIX GROUP
25.21.1 BUSINESS OVERVIEW
25.21.2 SERVICE OFFERINGS
25.22 PAREXEL INTERNATIONAL
25.22.1 BUSINESS OVERVIEW
25.22.2 SERVICE OFFERINGS
25.23 SEKO LOGISTICS
25.23.1 BUSINESS OVERVIEW
25.23.2 SERVICE OFFERINGS
25.24 SINGAPORE POST
25.24.1 BUSINESS OVERVIEW
25.24.2 SERVICE OFFERINGS
25.25 SINOTRANS
25.25.1 BUSINESS OVERVIEW
25.25.2 SERVICE OFFERINGS
25.26 XPO LOGISTICS
25.26.1 BUSINESS OVERVIEW
25.26.2 SERVICE OFFERINGS
25.27 YOURWAY
25.27.1 BUSINESS OVERVIEW
25.27.2 SERVICE OFFERINGS
25.28 YUSEN LOGISTICS
25.28.1 BUSINESS OVERVIEW
25.28.2 SERVICE OFFERINGS
26 REPORT SUMMARY
26.1 KEY TAKEAWAYS
26.2 STRATEGIC RECOMMENDATIONS
27 QUANTITATIVE SUMMARY
27.1 MARKET BY GEOGRAPHY
27.2 MARKET BY THERAPY AREA
27.3 MARKET BY ORIGIN
27.4 MARKET BY PRODUCT
27.5 MARKET BY FUNCTION
27.6 NORTH AMERICA BY THERAPY AREA
27.7 NORTH AMERICA BY ORIGIN
27.8 NORTH AMERICA BY PRODUCT
27.9 NORTH AMERICA BY FUNCTION
27.10 EUROPE BY THERAPY AREA
27.11 EUROPE BY ORIGIN
27.12 EUROPE BY PRODUCT
27.13 EUROPE BY FUNCTION
27.14 APAC BY THERAPY AREA
27.15 APAC BY ORIGIN
27.16 APAC BY PRODUCT
27.17 APAC BY FUNCTION
27.18 LATIN AMERICA BY THERAPY AREA
27.19 LATIN AMERICA BY ORIGIN
27.20 LATIN AMERICA BY PRODUCT
27.21 LATIN AMERICA BY FUNCTION
27.22 MIDDLE EAST & AFRICA AMERICA BY THERAPY AREA
27.23 MIDDLE EAST & AFRICA BY ORIGIN
27.24 MIDDLE EAST & AFRICA BY PRODUCT
27.25 MIDDLE EAST & AFRICA BY FUNCTION
28 APPENDIX
28.1 ABBREVIATIONS
EXHIBIT 1 SEGMENTATION OF GLOBAL PHARMACEUTICAL LOGISTICS MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 GLOBAL PHARMACEUTICAL INDUSTRY 2003-2020 ($ TRILLIONS)
EXHIBIT 4 DSCSA IMPLEMENTATION TIMELINE
EXHIBIT 5 SUPPLY CHAIN ANALYSIS DURING COVID-19 PANDEMIC
EXHIBIT 6 ESTIMATED GROWTH OF ORIGIN SEGMENTATION BETWEEN 2021 AND 2027
EXHIBIT 7 GLOBAL PHARMACEUTICAL LOGISTICS MARKET REVENUE BY REGION, 2021
EXHIBIT 8 IMPACT OF GROWING DEMAND FOR CLINICAL TRIALS LOGISTICS
EXHIBIT 9 NUMBER OF CLINICAL TRIALS PER YEAR, BY INCOME GROUP, 2015-2019
EXHIBIT 10 IMPACT OF DIGITAL TRANSFORMATIONS IN PHARMA LOGISTICS
EXHIBIT 11 TOP FOUR TECHNOLOGY TRENDS THAT CAN DISRUPT GLOBAL LOGISTICS LANDSCAPE
EXHIBIT 12 IMPACT OF INCREASING DEMAND FOR CELL & GENE THERAPY LOGISTICS
EXHIBIT 13 M&A ACTIVITY IN THE CGT INDUSTRY (DEAL VALUE: $ BILLION), 2019
EXHIBIT 14 TOTAL GLOBAL REGENERATIVE MEDICINE FINANCING ($ BILLION)
EXHIBIT 15 CELL AND GENE THERAPY: LANDSCAPE AS OF 2021 AND FUTURE POTENTIAL
EXHIBIT 16 IMPACT OF INCREASING DEMAND FOR TEMPERATURE-SENSITIVE MEDICINES
EXHIBIT 17 GLOBAL BIOPHARMACEUTICAL COLD CHAIN SPENDING ($ BILLION)
EXHIBIT 18 IMPACT OF GROWING DEMAND FOR OCEAN FREIGHT SERVICE
EXHIBIT 19 IMPACT OF INCREASING DEMAND FOR GENERICS AND BIOSIMILARS
EXHIBIT 20 LEADING COUNTRIES IN GENERICS MARKET (AS OF 2019)
EXHIBIT 21 AGGREGATE VALUE OF GLOBAL PHARMACEUTICAL INDUSTRY 2014-2021 ($ TRILLIONS)
EXHIBIT 22 IMPACT OF LACK OF COMPLIANCE AND CHANGING REGULATIONS
EXHIBIT 23 COSTS INCURRED DUE TO TEMPERATURE DEVIATIONS, 2019 ($ BILLION)
EXHIBIT 24 IMPACT OF COVID-19 PANDEMIC
EXHIBIT 25 PERCENTAGE OF MANUFACTURERS REPORTED SUPPLY CHAIN INTERRUPTIONS AND DIFFICULTIES, 2020
EXHIBIT 26 IMPACT OF GEOPOLITICAL RISKS & CHANGES IN INTERNATIONAL TRADE POLICIES AND RELATIONS
EXHIBIT 27 GLOBAL PHARMACEUTICAL LOGISTICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 28 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021 & 2027 (%)
EXHIBIT 29 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021 & 2027 (%)
EXHIBIT 30 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021 & 2027 (%)
EXHIBIT 31 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021 & 2027 (%)
EXHIBIT 32 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY GEOGRAPHY 2021 & 2027 (%)
EXHIBIT 33 FIVE FORCES ANALYSIS 2021
EXHIBIT 34 INCREMENTAL GROWTH BY THERAPY AREA 2021 & 2027
EXHIBIT 35 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA
EXHIBIT 36 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA: IMPACT FACTOR
EXHIBIT 37 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 38 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA: ABSOLUTE GROWTH (%)
EXHIBIT 39 TOTAL CONFIRMED MONKEYPOX CASES AS OF NOVEMBER 7, 2022
EXHIBIT 40 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY COMMUNICABLE DISEASES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 41 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY COMMUNICABLE DISEASES 2021–2027 ($ BILLION)
EXHIBIT 42 COMMUNICABLE DISEASES: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 43 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ONCOLOGY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 44 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ONCOLOGY 2021–2027 ($ BILLION)
EXHIBIT 45 ONCOLOGY: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 46 MOST COMMON MEDICATIONS FOR TYPE 2 DIABETES
EXHIBIT 47 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY DIABETES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 48 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY DIABETES 2021–2027 ($ BILLION)
EXHIBIT 49 DIABETES: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 50 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY CVD: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 51 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY CARDIOVASCULAR DISEASES 2021–2027 ($ BILLION)
EXHIBIT 52 CARDIOVASCULAR DISEASES: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 53 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY AUTOIMMUNE DISEASES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 54 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY AUTOIMMUNE DISEASES 2021–2027 ($ BILLION)
EXHIBIT 55 AUTOIMMUNE DISEASES: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 56 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY NEUROLOGICAL DISORDERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 57 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY NEUROLOGICAL DISORDERS 2021–2027 ($ BILLION)
EXHIBIT 58 NEUROLOGICAL DISORDERS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 59 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY PAIN MANAGEMENT: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 60 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY PAIN MANAGEMENT 2021–2027 ($ BILLION)
EXHIBIT 61 PAIN MANAGEMENT: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 62 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY RESPIRATORY DISEASES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 63 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY RESPIRATORY DISEASES 2021–2027 ($ BILLION)
EXHIBIT 64 RESPIRATORY DISEASES: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 65 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 66 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY OTHERS 2021–2027 ($ BILLION)
EXHIBIT 67 OTHERS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 68 INCREMENTAL GROWTH BY ORIGIN 2021 & 2027
EXHIBIT 69 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN
EXHIBIT 70 TOTAL SPENDING ON BRANDED AND GENERIC DRUGS, US (%SHARE)
EXHIBIT 71 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 72 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN: ABSOLUTE GROWTH (%)
EXHIBIT 73 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN: IMPACT FACTOR
EXHIBIT 74 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY BRANDED DRUGS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 75 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY BRANDED DRUGS 2021–2027 ($ BILLION)
EXHIBIT 76 BRANDED DRUGS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 77 ESTIMATED SAVINGS FROM GENERIC DRUG APPROVALS ($ BILLION)
EXHIBIT 78 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY GENERIC DRUGS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 79 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY GENERIC DRUGS 2021–2027 ($ BILLION)
EXHIBIT 80 GENERIC DRUGS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 81 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY OTC: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 82 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY OTC 2021–2027 ($ BILLION)
EXHIBIT 83 OTC: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 84 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 85 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT
EXHIBIT 86 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT: IMPACT FACTOR
EXHIBIT 87 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 88 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT: ABSOLUTE GROWTH (%)
EXHIBIT 89 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY SMALL MOLECULE DRUGS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 90 NUMBER OF SMALL MOLECULE DRUGS APPROVED AS NMES BY FDA, 2017-2021
EXHIBIT 91 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY SMALL MOLECULE DRUGS 2021–2027 ($ BILLION)
EXHIBIT 92 SMALL MOLECULE DRUGS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 93 NUMBER OF BIOLOGICS APPROVED AS NMES BY FDA, 2017-2021
EXHIBIT 94 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY BIOLOGICS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 95 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY BIOLOGICS 2021–2027 ($ BILLION)
EXHIBIT 96 BIOLOGICS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 97 TOP MABS SALES BY GLOBAL SALES, 2019 ($ BILLION)
EXHIBIT 98 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY MONOCLONAL ANTIBODIES 2021–2027 ($ BILLION)
EXHIBIT 99 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY VACCINES 2021–2027 ($ BILLION)
EXHIBIT 100 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY OTHERS 2021–2027 ($ BILLION)
EXHIBIT 101 INCREMENTAL GROWTH BY FUNCTION 2021 & 2027
EXHIBIT 102 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION
EXHIBIT 103 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION: IMPACT FACTOR
EXHIBIT 104 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 105 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION: ABSOLUTE GROWTH (%)
EXHIBIT 106 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY TRANSPORTATION: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 107 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY TRANSPORTATION 2021–2027 ($ BILLION)
EXHIBIT 108 TRANSPORTATION: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 109 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ROAD 2021–2027 ($ BILLION)
EXHIBIT 110 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY WATER 2021–2027 ($ BILLION)
EXHIBIT 111 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY AIR 2021–2027 ($ BILLION)
EXHIBIT 112 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY WAREHOUSING: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 113 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY WAREHOUSING 2021–2027 ($ BILLION)
EXHIBIT 114 WAREHOUSING: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 115 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 116 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY OTHERS 2021–2027 ($ BILLION)
EXHIBIT 117 OTHERS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 118 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 119 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY GEOGRAPHY
EXHIBIT 120 GEOGRAPHICAL SEGMENTATION OF SALES OF NEW MEDICINES LAUNCHED, 2015-2020 (%)
EXHIBIT 121 PHARMACEUTICAL R&D EXPENDITURE- ANNUAL GROWTH RATE 2006-2020 (%)
EXHIBIT 122 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 123 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH (%)
EXHIBIT 124 PERCENTAGE OF API MANUFACTURING FACILITIES FOR ALL DRUGS BY COUNTRY OR REGION, AUGUST 2019
EXHIBIT 125 NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 126 NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET: KEY COUNTRIES 2021 ($ BILLION)
EXHIBIT 127 PHARMACEUTICAL LOGISTICS MARKET IN NORTH AMERICA 2021–2027 ($ BILLION)
EXHIBIT 128 INCREMENTAL GROWTH BY THERAPY AREA 2021 & 2027
EXHIBIT 129 INCREMENTAL GROWTH BY ORIGIN 2021 & 2027
EXHIBIT 130 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 131 INCREMENTAL GROWTH BY FUNCTION 2021 & 2027
EXHIBIT 132 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 133 US PHARMACEUTICAL SALES FROM 2017-2021 ($ BILLION)
EXHIBIT 134 PHARMACEUTICAL LOGISTICS MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 135 IMPORTS AND EXPORTS OF PHARMACEUTICAL AND MEDICINAL PRODUCTS, NOVEMBER 2019−NOVEMBER 2021 ($ MILLION)
EXHIBIT 136 PHARMACEUTICAL LOGISTICS MARKET IN CANADA 2021–2027 ($ BILLION)
EXHIBIT 137 EUROPEAN PHARMACEUTICAL MANUFACTURING VALUE, 2019 ($ MILLION)
EXHIBIT 138 EUROPE PHARMACEUTICAL LOGISTICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 139 EUROPE PHARMACEUTICAL LOGISTICS MARKET: KEY COUNTRIES 2021 ($ BILLION)
EXHIBIT 140 PHARMACEUTICAL LOGISTICS MARKET IN EUROPE 2021–2027 ($ BILLION)
EXHIBIT 141 INCREMENTAL GROWTH BY THERAPY AREA 2021 & 2027
EXHIBIT 142 INCREMENTAL GROWTH BY ORIGIN 2021 & 2027
EXHIBIT 143 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 144 INCREMENTAL GROWTH BY FUNCTION 2021 & 2027
EXHIBIT 145 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 146 TOTAL DRUG SALES IN GERMAN PHARMACY MARKET, 2019 (MILLION PACKAGING UNITS)
EXHIBIT 147 PHARMACEUTICAL PRODUCTION IN GERMANY, 2015-2018 ($ BILLION)
EXHIBIT 148 PRODUCT GROUPS EXPORTED BY AIR FREIGHT, 2017 ($ BILLION)
EXHIBIT 149 PHARMACEUTICAL LOGISTICS MARKET IN GERMANY 2021–2027 ($ BILLION)
EXHIBIT 150 SALES REVENUE OF OTC PHARMACEUTICALS, 2017-2021 ($ MILLION)
EXHIBIT 151 PHARMACEUTICAL LOGISTICS MARKET IN FRANCE 2021–2027 ($ BILLION)
EXHIBIT 152 GROWTH OF PHARMACEUTICAL WHOLESALE IN UK, 2016-2021
EXHIBIT 153 RECORDED DRUG CRIME IN ENGLAND AND WALES BETWEEN 2019-2020 AND 2020-2021
EXHIBIT 154 PHARMACEUTICAL LOGISTICS MARKET IN UK 2021–2027 ($ BILLION)
EXHIBIT 155 PHARMA INDUSTRY IN ITALY BY OWNERSHIP (% OF TOTAL)
EXHIBIT 156 EXPORT SALES OF PHARMACEUTICAL ITALIAN-OWNED COMPANIES (% OF OVERALL TURNOVER)
EXHIBIT 157 BIOSIMILAR CONSUMPTION IN 2018
EXHIBIT 158 PHARMACEUTICAL LOGISTICS MARKET IN ITALY 2021–2027 ($ BILLION)
EXHIBIT 159 OTC PHARMACEUTICALS TOTAL REVENUE, 2017-2021
EXHIBIT 160 PHARMACEUTICAL LOGISTICS MARKET IN SPAIN 2021–2027 ($ BILLION)
EXHIBIT 161 PHARMACEUTICAL SPENDING BY APAC COUNTRIES, 2018 ($ BILLION)
EXHIBIT 162 APAC PHARMACEUTICAL LOGISTICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 163 APAC PHARMACEUTICAL LOGISTICS MARKET: KEY COUNTRIES 2021 ($ BILLION)
EXHIBIT 164 PHARMACEUTICAL LOGISTICS MARKET IN APAC 2021–2027 ($ BILLION)
EXHIBIT 165 INCREMENTAL GROWTH BY THERAPY AREA 2021 & 2027
EXHIBIT 166 INCREMENTAL GROWTH BY ORIGIN 2021 & 2027
EXHIBIT 167 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 168 INCREMENTAL GROWTH BY FUNCTION 2021 & 2027
EXHIBIT 169 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 170 REVENUE SEGMENTATION OF PHARMACEUTICAL INDUSTRY IN CHINA, 2018 ($ BILLION)
EXHIBIT 171 TOTAL PHARMACEUTICAL COLD CHAIN LOGISTICS COST OF CHINA, 2018−2021
EXHIBIT 172 PHARMACEUTICAL LOGISTICS MARKET IN CHINA 2021–2027 ($ BILLION)
EXHIBIT 173 PHARMACEUTICAL LOGISTICS MARKET IN JAPAN 2021–2027 ($ BILLION)
EXHIBIT 174 BIOSIMILARS APPROVED BY COUNTRY AND REGION, 2019
EXHIBIT 175 INTERNATIONAL TRADE (EXPORT) IN PHARMACEUTICALS ($ BILLION)
EXHIBIT 176 INDIA'S DRUG AND PHARMACEUTICAL EXPORT TREND ($ BILLION)
EXHIBIT 177 MEDICINAL DRUG EXPORTS BY INDIA (2021-22)
EXHIBIT 178 PHARMACEUTICAL LOGISTICS MARKET IN INDIA 2021–2027 ($ BILLION)
EXHIBIT 179 DRUG EXPENDITURE DYNAMICS 1995-2020
EXHIBIT 180 PHARMACEUTICAL LOGISTICS MARKET IN SOUTH KOREA 2021–2027 ($ BILLION)
EXHIBIT 181 PHARMACEUTICAL LOGISTICS MARKET IN AUSTRALIA 2021–2027 ($ BILLION)
EXHIBIT 182 LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 183 LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET: KEY COUNTRIES 2021 ($ BILLION)
EXHIBIT 184 PHARMACEUTICAL LOGISTICS MARKET IN LATIN AMERICA 2021–2027 ($ BILLION)
EXHIBIT 185 INCREMENTAL GROWTH BY THERAPY AREA 2021 & 2027
EXHIBIT 186 INCREMENTAL GROWTH BY ORIGIN 2021 & 2027
EXHIBIT 187 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 188 INCREMENTAL GROWTH BY FUNCTION 2021 & 2027
EXHIBIT 189 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 190 PHARMACEUTICAL LOGISTICS MARKET IN BRAZIL 2021–2027 ($ BILLION)
EXHIBIT 191 PHARMACEUTICAL LOGISTICS MARKET IN MEXICO 2021–2027 ($ BILLION)
EXHIBIT 192 SALES OF PHARMACEUTICAL INDUSTRY 2017-2021 ($ BILLION)
EXHIBIT 193 OTC SALES 2017−2020 (%)
EXHIBIT 194 PHARMACEUTICAL EXPORTS AND IMPORTS 2017−2021 ($ BILLION)
EXHIBIT 195 PHARMACEUTICAL LOGISTICS MARKET IN ARGENTINA 2021–2027 ($ BILLION)
EXHIBIT 196 MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 197 MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET: KEY COUNTRIES 2021 ($ BILLION)
EXHIBIT 198 PHARMACEUTICAL LOGISTICS MARKET IN MIDDLE EAST & AFRICA 2021–2027 ($ BILLION)
EXHIBIT 199 INCREMENTAL GROWTH BY THERAPY AREA 2021 & 2027
EXHIBIT 200 INCREMENTAL GROWTH BY ORIGIN 2021 & 2027
EXHIBIT 201 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 202 INCREMENTAL GROWTH BY FUNCTION 2021 & 2027
EXHIBIT 203 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 204 % SHARE OF BIOSIMILARS BY THERAPEUTIC AREAS, 2020 (%)
EXHIBIT 205 TURKEY PHARMACEUTICALS MARKET COMPOSITION, 2019 ($ BILLION)
EXHIBIT 206 TURKEY PHARMACEUTICALS MARKET COMPOSITION, 2019 ($ BILLION)
EXHIBIT 207 PHARMACEUTICAL LOGISTICS MARKET IN TURKEY 2021–2027 ($ BILLION)
EXHIBIT 208 SAUDI ARABIA PHARMACEUTICALS MARKET COMPOSITION, 2019 ($ BILLION)
EXHIBIT 209 PHARMACEUTICAL LOGISTICS MARKET IN SAUDI ARABIA 2021–2027 ($ BILLION)
EXHIBIT 210 PHARMACEUTICAL LOGISTICS MARKET IN SOUTH AFRICA 2021–2027 ($ BILLION)
EXHIBIT 211 GLOBAL PHARMACEUTICAL LOGISTICS MARKET: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 212 GLOBAL PHARMACEUTICAL LOGISTICS MARKET – MARKET DOMINANT ANALYSIS
EXHIBIT 213 AMERISOURCEBERGEN: TOTAL REVENUE, 2019-2021 ($ MILLION)
EXHIBIT 214 DB GROUP: TOTAL REVENUE 2019−2021 ($ MILLION)
EXHIBIT 215 DB GROUP: DG SCHENKER SUBSIDIARY REVENUE 2019-2021 ($ MILLION)
EXHIBIT 216 DB GROUP: NET CAPITAL EXPENDITURE, 2019-2021 ($ MILLION)
EXHIBIT 217 DEUTSCHE POST DHL GROUP: TOTAL REVENUE 2019-2021 ($ MILLION)
EXHIBIT 218 FEDEX REVENUE, 2019−2021
EXHIBIT 219 FEDEX CORPORATION: MAJOR SERVICE OFFERINGS
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 PERCENTAGE SHARE OF VARIOUS BIOPHARMACEUTICALS BETWEEN 2015 AND 2020
TABLE 4 COMMONLY PRESCRIBED MEDICATIONS ($ BILLION)
TABLE 5 POPULAR MEDICATIONS BY NUMBER OF MONTHLY PRESCRIPTIONS ANNUALLY (MILLIONS)
TABLE 6 TOP TEN BRANDED DRUGS SOLD BY RETAIL SALES, 2021 ($ BILLION)
TABLE 7 TOP SELLING OTC DRUGS AND REVENUE, ($ MILLION) 2018
TABLE 8 TOP 10 SMALL MOLECULE DRUGS BY SALES, 2021 ($ BILLION)
TABLE 9 TOP 10 EXPORTERS AND IMPORTERS OF HUMAN-USE VACCINES, 2020
TABLE 10 TOP SIX BEST-SELLING VACCINES, 2021 ($ BILLION)
TABLE 11 SALES OF PATENTED AND NON-PATENTED DRUGS BY CANADIAN MANUFACTURERS, 2011−2019 ($ BILLION)
TABLE 12 HEALTH EXPENDITURE OF CANADIANS, 2011−2019 ($ BILLION)
TABLE 13 TOTAL PHARMACEUTICALS MARKET ($ THOUSANDS), 2017−2020
TABLE 14 MEXICO PHARMACEUTICAL MARKET, 2018-2020 ($ BILLION)
TABLE 15 AMERISOURCEBERGEN: MAJOR SERVICE OFFERINGS
TABLE 16 CEVA LOGISTICS: MAJOR SERVICE OFFERINGS
TABLE 17 DB SCHENKER: MAJOR SERVICE OFFERINGS
TABLE 18 DEUTSCHE POST DHL GROUP: MAJOR SERVICE OFFERINGS
TABLE 19 KUEHNE + NAGEL: MAJOR SERVICE OFFERINGS
TABLE 20 UNITED PARCEL SERVICE: MAJOR SERVICE OFFERINGS
TABLE 21 ABS LOGISTICS: MAJOR SERVICE OFFERINGS
TABLE 22 AWL INDIA: MAJOR SERVICE OFFERINGS
TABLE 23 ALLOGA: MAJOR SERVICE OFFERINGS
TABLE 24 BOLLORÉ LOGISTICS: MAJOR SERVICE OFFERINGS
TABLE 25 CARDINAL HEALTH: MAJOR SERVICE OFFERINGS
TABLE 26 C.H. ROBINSON: MAJOR SERVICE OFFERINGS
TABLE 27 COLD CHAIN TECHNOLOGIES: MAJOR SERVICE OFFERINGS
TABLE 28 CRYOPDP: MAJOR SERVICE OFFERINGS
TABLE 29 DPD: MAJOR SERVICE OFFERINGS
TABLE 30 DSV: MAJOR SERVICE OFFERINGS
TABLE 31 FARMASOFT: MAJOR SERVICE OFFERINGS
TABLE 32 JEENA & COMPANY: MAJOR SERVICE OFFERINGS
TABLE 33 LUFTHANSA CARGO: MAJOR SERVICE OFFERINGS
TABLE 34 A.P. MOLLER - MAERSK: MAJOR SERVICE OFFERINGS
TABLE 35 MEDLINE: MAJOR SERVICE OFFERINGS
TABLE 36 NIPPON EXPRESS: MAJOR SERVICE OFFERINGS
TABLE 37 NOATUM LOGISTICS: MAJOR SERVICE OFFERINGS
TABLE 38 OWENS & MINOR: MAJOR SERVICE OFFERINGS
TABLE 39 OXIMIO: MAJOR SERVICE OFFERINGS
TABLE 40 PHARMA LOGISTICS: MAJOR SERVICE OFFERINGS
TABLE 41 PHOENIX GROUP: MAJOR SERVICE OFFERINGS
TABLE 42 PAREXEL INTERNATIONAL: MAJOR SERVICE OFFERINGS
TABLE 43 SEKO LOGISTICS: MAJOR SERVICE OFFERINGS
TABLE 44 SINGAPORE POST: MAJOR SERVICE OFFERINGS
TABLE 45 SINOTRANS: MAJOR SERVICE OFFERINGS
TABLE 46 XPO LOGISTICS: MAJOR SERVICE OFFERINGS
TABLE 47 YOURWAY: MAJOR SERVICE OFFERINGS
TABLE 48 YUSEN LOGISTICS: MAJOR SERVICE OFFERINGS
TABLE 49 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 50 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 51 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021−2027 ($ BILLION)
TABLE 52 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021−2027 (%)
TABLE 53 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021−2027 ($ BILLION)
TABLE 54 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021−2027 (%)
TABLE 55 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021−2027 ($ BILLION)
TABLE 56 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021−2027 (%)
TABLE 57 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021−2027 ($ BILLION)
TABLE 58 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021−2027 (%)
TABLE 59 NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021−2027 ($ BILLION)
TABLE 60 NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021−2027 (%)
TABLE 61 NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021−2027 ($ BILLION)
TABLE 62 NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021−2027 (%)
TABLE 63 NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021−2027 ($ BILLION)
TABLE 64 NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021−2027 (%)
TABLE 65 NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021−2027 ($ BILLION)
TABLE 66 NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021−2027 (%)
TABLE 67 EUROPE PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021−2027 ($ BILLION)
TABLE 68 EUROPE PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021−2027 (%)
TABLE 69 EUROPE PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021−2027 ($ BILLION)
TABLE 70 EUROPE PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021−2027 (%)
TABLE 71 EUROPE PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021−2027 ($ BILLION)
TABLE 72 EUROPE PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021−2027 (%)
TABLE 73 EUROPE PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021−2027 ($ BILLION)
TABLE 74 EUROPE PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021−2027 (%)
TABLE 75 APAC PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021−2027 ($ BILLION)
TABLE 76 APAC PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021−2027 (%)
TABLE 77 APAC PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021−2027 ($ BILLION)
TABLE 78 APAC PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021−2027 (%)
TABLE 79 APAC PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021−2027 ($ BILLION)
TABLE 80 APAC PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021−2027 (%)
TABLE 81 APAC PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021−2027 ($ BILLION)
TABLE 82 APAC PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021−2027 (%)
TABLE 83 LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021−2027 ($ BILLION)
TABLE 84 LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021−2027 (%)
TABLE 85 LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021−2027 ($ BILLION)
TABLE 86 LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021−2027 (%)
TABLE 87 LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021−2027 ($ BILLION)
TABLE 88 LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021−2027 (%)
TABLE 89 LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021−2027 ($ BILLION)
TABLE 90 LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021−2027 (%)
TABLE 91 MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021−2027 ($ BILLION)
TABLE 92 MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021−2027 (%)
TABLE 93 MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021−2027 ($ BILLION)
TABLE 94 MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021−2027 (%)
TABLE 95 MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021−2027 ($ BILLION)
TABLE 96 MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021−2027 (%)
TABLE 97 MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021−2027 ($ BILLION)
TABLE 98 MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021−2027 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
